VASC Financial Facts

Collaboration expenses: 0
Amortization of purchased technology and intangibles: 404K
See Full Income Statement

Accumulated deficit: 38.81M
Accumulated other comprehensive earnings: -1.16M
See Full Balance Sheet

Vascular Solutions (VASC) Earnings

  |   Expand Research on VASC
Next EPS Date 1/20/17 *Est. EPS Growth Rate +14.8% *Last Qtr.
Average EPS % Beat Rate +11.1% Revenue Growth Rate +13.0% *Last Qtr.
Average % Move 1-Wk after EPS -3.6% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
10/24/16 Q316 $0.31$0.30 +$0.01$41.8M$41.65M = Details
7/25/16 Q216 $0.33$0.30 +$0.03$41.2M$41.4M Details
4/25/16 Q116 $0.25$0.23 +$0.02$39M$38.37M Details
1/21/16 Q415 $0.33$0.27 +$0.06$38.1M$37.54M Details
10/20/15 Q315 $0.27$0.25 +$0.02$37M$36.41M Details
7/21/15 Q215 $0.29$0.25 +$0.04$37.6M$35.59M Details
4/21/15 Q115 $0.21$0.18 +$0.03$34.6M$33.38M Details
2/3/15 Q414 $0.23$0.18 +$0.05$33.6M$32.82M Details